Abstract
Creatine in its free and phosphorylated form plays an essential role for maintenance and distribution of ATP levels in tissues with high and fluctuating energy demands such as muscle, brain and heart. Alterations in the creatine concentration in these tissues produce marked functional changes. Creatine concentration is largely determined by a specific creatine transporter, a member of the Na+ dependent transporters family, that is localized on the cells plasma membrane. This transporter is needed to carry creatine into the cells against a high concentration gradient. In recent years the mechanisms regulating the expression and the function of this transporter are being unraveled. Even if our knowledge of this matter is still limited, we have now tools for either stimulating or inhibiting this transporter, tools that may be relevant to several experimental and clinical conditions. This review will examine the data and the tools that are available in relation to the regulation and expression of the creatine transporter. Furthermore, we will briefly review the possible practical relevance of manipulating the creatine transporter activity.
Keywords: Creatine, phosphocreatine, creatine transporter, SLC6A8, inhibition, stimulation
Current Enzyme Inhibition
Title: Controlling the Flow of Energy: Inhibition and Stimulation of the Creatine Transporter
Volume: 5 Issue: 4
Author(s): Maurizio Balestrino, Carlo Gandolfo and Luisa Perasso
Affiliation:
Keywords: Creatine, phosphocreatine, creatine transporter, SLC6A8, inhibition, stimulation
Abstract: Creatine in its free and phosphorylated form plays an essential role for maintenance and distribution of ATP levels in tissues with high and fluctuating energy demands such as muscle, brain and heart. Alterations in the creatine concentration in these tissues produce marked functional changes. Creatine concentration is largely determined by a specific creatine transporter, a member of the Na+ dependent transporters family, that is localized on the cells plasma membrane. This transporter is needed to carry creatine into the cells against a high concentration gradient. In recent years the mechanisms regulating the expression and the function of this transporter are being unraveled. Even if our knowledge of this matter is still limited, we have now tools for either stimulating or inhibiting this transporter, tools that may be relevant to several experimental and clinical conditions. This review will examine the data and the tools that are available in relation to the regulation and expression of the creatine transporter. Furthermore, we will briefly review the possible practical relevance of manipulating the creatine transporter activity.
Export Options
About this article
Cite this article as:
Balestrino Maurizio, Gandolfo Carlo and Perasso Luisa, Controlling the Flow of Energy: Inhibition and Stimulation of the Creatine Transporter, Current Enzyme Inhibition 2009; 5 (4) . https://dx.doi.org/10.2174/157340809789630299
DOI https://dx.doi.org/10.2174/157340809789630299 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mitochondrial Diseases in Childhood
Current Molecular Medicine Development of Polymeric Nanocarriers for Brain Targeted Delivery of Atorvastatin: A Quality-By-Design Approach
Drug Delivery Letters Neuroimaging of Non-Accidental Injury
Current Pediatric Reviews Lamotrigine as an Effective Treatment for Behavioral Disorders
Letters in Drug Design & Discovery Recent Advances in the Treatment of Amyotrophic Lateral Sclerosis. Emphasis on Kynurenine Pathway Inhibitors
Central Nervous System Agents in Medicinal Chemistry Introduction to the Special Issue “Pharmacotherapies for the Treatment of Alcohol Abuse and Dependence” and a Summary of Patents Targeting other Neurotransmitter Systems
Recent Patents on CNS Drug Discovery (Discontinued) A Review on Mechanistic and Pharmacological Findings of Diabetic Peripheral Neuropathy including Pharmacotherapy
Current Diabetes Reviews Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Voltage-Gated Sodium Channels and Pain
Current Drug Targets - CNS & Neurological Disorders Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Current Biotechnology Synthesis of Novel 1-benzhydryl-4-(3-(piperidin-4-yl)propyl) Piperidine Sulfonamides as Anticonvulsant Agents
Letters in Drug Design & Discovery Quality of Life of Children with Cerebral Palsy: A Cross-Sectional KIDSCREEN study in the Southern part of the Netherlands
CNS & Neurological Disorders - Drug Targets Genetics and Molecular Biology of Tuberous Sclerosis Complex
Current Genomics A Review of Agents Patented for their Neuroprotective Properties
Recent Patents on CNS Drug Discovery (Discontinued) Complex and Differential Glial Responses in Alzheimer´s Disease and Ageing
Current Alzheimer Research Inflammation and Neurogenesis in Temporal Lobe Epilepsy
Current Drug Targets - CNS & Neurological Disorders Is There a Relationship Between Sweet Taste and Seizures? Anticonvulsant and Proconvulsant Effects of Non-Nutritive Sweeteners
Combinatorial Chemistry & High Throughput Screening Role of SCN2A c.56G/A Gene Polymorphism in Egyptian Children with Genetic Epilepsy with Febrile Seizure Plus
CNS & Neurological Disorders - Drug Targets Acute Symptomatic Seizures in Geriatric Patients with Multiple Risk Factors - A Diagnostic Challenge
Current Aging Science <i>In Vivo</i> Longitudinal Monitoring of Changes in the Corpus Callosum Integrity During Disease Progression in a Mouse Model of Alzheimer’s Disease
Current Alzheimer Research